Meeting The Unmet Need in Drug DeliveryPartnering
Management
Mr. Giora Carni, Chief Executive Officer
ImageMr. Carni has over 34 years of experience in the global pharmaceutical industry throughout Israel and North America. Mr. Carni has held various executive positions in the "Agis Group", a leading Israeli pharmaceutical group. Mr Carni served as President and CEO of Clay Park Labs in New York for more than10 years. An industrial engineer by training, Mr. Carni holds a degree in Industrial Engineering from the Technion in Haifa, Israel.
 
Mr. Zeev Weiss , Executive Vice President, Commercial Operations
ImageMr. Weiss has over 10 years of experience in healthcare corporate development, strategic planning and corporate finance. Prior to joining Intec Pharma, he served as Head of Life Sciences Strategic Consulting with PwC Israel, leading numerous business development and corporate strategy projects for many biopharmaceutical and medical device companies throughout the Israeli industry. Mr. Weiss is a CPA, and has completed BSc studies in Biology, MSc studies in Neuro-Biochemistry, and BA studies in accounting, all at Tel Aviv University.
 
Mrs. Hadas Friedman, Vice president QA / Clinical & Regulatory Affairs
ImageMrs. Hadas Friedman, certified by both the American and Israeli quality societies as a Quality Manager, has served as a Quality Manager for Procognia Ltd., a biotech company specializing in micro-array technologies for glycoanalysis. Prior to that, she served as an associate in the quality department in Rafa Laboratories, Jerusalem, in sterile production. She also has training and certification as a Clinical Research Associate (CRA) and as a clinical trials auditor. She holds an MSc in molecular biology and BSc in Life Sciences from Bar-Ilan University in Israel.
 
Dr. Nadav Navon - Vice president Research & Development
ImageDr. Navon joined Intec Pharma in 2006 as the Analytical R&D Manager. Before joining Intec, he headed the analytical and quality assurance operations at Sharon Laboratories Ltd., a chemical company developing and manufacturing raw materials for the pharmaceutical, cosmetic and food industries. Prior to that, Dr. Navon led a number of R&D projects in the Negev’s Nuclear Research Center.  Dr. Navon has a PhD in inorganic and analytical chemistry and an MBA from Ben-Gurion University in Israel.